|
Originally published In Press as doi:10.1194/jlr.M200273-JLR200 on March 1, 2003
Journal of Lipid Research, Vol. 44, 884-892, May 2003
Copyright © 2003 by Lipid Research, Inc.
Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles
Larbi Krimbou*,
Michel Marcil*,
Hitoshi Chiba and
Jacques Genest, Jr.1,*
* Cardiovascular Genetics Laboratory, McGill University Health Center/Royal Victoria Hospital, Montréal, Québec H3A 1A1, Canada
Department of Laboratory Medicine, Hokkaido University School of Medicine, North-14, West-5, Sapporo 060-8648, Japan
1 To whom correspondence should be addressed. e-mail: jacques.genest{at}muhc.mcgill.ca
To investigate the metabolism of HDL-apolipoprotein E (apoE) particles in human plasma, we isolated a fraction of plasma HDL-apoEs that lack apoA-I (HDL-LpE) from subjects with apoE3/3 phenotype by immunoaffinity. Plasma HDL-LpE had a particle size ranging from 9 nm to 18.5 nm in diameter and was characterized by two-dimensional nondenaturing gradient gel electrophoresis as having either -, preß1-, preß2-, or -electrophoretic mobility. HDL-LpE was also present in the medium of cultured human hepatoma cell lines and monocyte-derived macrophages. The majority of apoE3 was found as a monomeric form in HDL-LpE and floated at density d > 1.21 g/ml. Plasma levels of HDL-LpE in normolipidemic, CETP-deficient, and ABCA1-deficient subjects were 0.72 ± 0.15 mg/dl (n = 12), 1.77 ± 0.75 mg/dl (n = 3), and 0.55 ± 0.11 mg/dl (n = 3), respectively. The ratio of HDL-apoE containing apoA-I to HDL-LpE was significantly higher 4 h after a fat load, representing a 35 ± 9% increase (n = 3). Isolated plasma HDL-LpE3 was as effective as apoE3, reconstituted HDL particles, or apoA-I in promoting cellular cholesterol efflux.
These results demonstrate that 1) plasma HDL-LpE may have hepatogenous and macrophagic origins; 2) HDL-LpE was preserved even with large reductions in apoA-I-containing lipoproteins; 3) HDL-LpE was active in the transfer of apoE to triglyceride-rich lipoproteins, and 4) HDL-LpEs efficiently take up cell-derived cholesterol.
Abbreviations: ABCA1, ATP binding cassette A1; CE, cholesteryl ester; CETP, cholesteryl ester transfer protein; LpE, lipoprotein containing only apoE; PEG, polyethylene glycol; RCT, reverse cholesterol transport; TD, Tangier disease; TRL, triglyceride-rich lipoprotein; 2D-PAGGE, two-dimensional nondenaturing gradient gel electrophoresis Supplementary key words HDL-apoE hypoalphalipoproteinemia postprandial lipemia cholesterol efflux reverse cholesterol transport

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Catalano, Z. Julia, E. Frisdal, B. Vedie, N. Fournier, W. Le Goff, M. J. Chapman, and M. Guerin
Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2009;
29(2):
268 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Settasatian, P. J. Barter, and K.-A. Rye
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein
J. Lipid Res.,
January 1, 2008;
49(1):
115 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guerin, W. Le Goff, E. Duchene, Z. Julia, T. Nguyen, T. Thuren, C. L. Shear, and M. J. Chapman
Inhibition of CETP by Torcetrapib Attenuates the Atherogenicity of Postprandial TG-Rich Lipoproteins in Type IIB Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2008;
28(1):
148 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Yancey, H. Yu, M. F. Linton, and S. Fazio
A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam Cells
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
1123 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Rye, R. Bright, M. Psaltis, and P. J. Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
J. Lipid Res.,
May 1, 2006;
47(5):
1025 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest
Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines
J. Lipid Res.,
August 1, 2005;
46(8):
1668 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hajj Hassan, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest
Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release
J. Lipid Res.,
July 1, 2005;
46(7):
1457 - 1465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Raffai, S. M. Loeb, and K. H. Weisgraber
Apolipoprotein E Promotes the Regression of Atherosclerosis Independently of Lowering Plasma Cholesterol Levels
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2005;
25(2):
436 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr.
Molecular interactions between apoE and ABCA1: impact on apoE lipidation
J. Lipid Res.,
May 1, 2004;
45(5):
839 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Haidar, M. Denis, M. Marcil, L. Krimbou, and J. Genest Jr.
Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter
J. Biol. Chem.,
March 12, 2004;
279(11):
9963 - 9969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Denis, B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest Jr.
Molecular and Cellular Physiology of Apolipoprotein A-I Lipidation by the ATP-binding Cassette Transporter A1 (ABCA1)
J. Biol. Chem.,
February 27, 2004;
279(9):
7384 - 7394.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|